Epigenetic fields for cancerization are involved in development of human cancers, especially those associated with inflammation and multiple occurrences. However, it is still unclear when such field defects are formed and what component of inflammation is involved in induction of aberrant DNA methylation. Here, in a mouse colitis model induced by dextran sulfate sodium (DSS), we identified three CpG islands specifically methylated in colonic epithelial cells exposed to colitis. Their methylation levels started to increase as early as 8 weeks after DSS treatment and continued to increase until colon cancers developed at 15 weeks. In contrast to the temporal profile of DNA methylation levels, infiltration of inflammatory cells spiked immediately after the DSS treatment and then gradually decreased. Exposure of cultured colonic epithelial cells to DSS did not induce DNA methylation and it was indicated that inflammation triggered by the DSS treatment was responsible for methylation induction. To clarify components of inflammation involved, severe combined immunodeficiency (SCID) mice that lack functional T-and B-cells were similarly treated. Even in SCID mice, DNA methylation, along with colon tumors, were induced at the same levels as in their background strain of mice (C.B17). Comparative analysis of inflammation-related genes showed that Ifng, Il1b and Nos2 had expression concordant with methylation induction whereas Il2, Il6, Il10, Tnf did not. These results showed that an epigenetic field defect is formed at early stages of colitis-associated carcinogenesis and that functional T and B cells are non-essential for the formation.
Introduction
Epigenetic alterations are critically involved in human carcinogenesis (Jones and Baylin, 2007; Esteller, 2008) . Especially, DNA methylation is stably inherited upon somatic cell replication (Riggs and Xiong, 2004) and methylation of promoter CpG islands (CGIs) consistently inactivates their downstream genes, including tumor-suppressor genes, such as CDK2A, HIC1 and SOCS1 (Ushijima, 2005) . In spite of its importance, inducers of aberrant DNA methylation are still not fully understood. Among the few established inducers, importance of chronic inflammation, such as ulcerative colitis, hepatitis and gastritis due to Helicobacter pylori infection, has been shown by multiple studies (Hsieh et al., 1998; Kondo et al., 2000; Issa et al., 2001; Niwa et al., 2010; Hur et al., 2011) . In addition to chronic inflammation, aging and exogenous DNA, such as viruses, have been considered as inducers (Ushijima and Okochi-Takada, 2005) .
Chronic inflammation-associated cancers are characterized by frequent occurrence of multiple cancers, suggesting that non-cancerous tissues exposed to chronic inflammation have already accumulated genetic and epigenetic alterations, forming a field for cancerization (Braakhuis et al., 2003; Ushijima, 2007) . Accumulation of genetic alterations is difficult to assess because their frequency in non-cancerous tissues is very low (Nagao et al., 2001) . In contrast, aberrant DNA methylation of various genes is accumulated at high levels in noncancerous tissues exposed to chronic inflammation (Hsieh et al., 1998; Kondo et al., 2000; Issa et al., 2001) , and such accumulation levels are correlated with cancer risk (Schulmann et al., 2005; Maekita et al., 2006; Nakajima et al., 2006; Garrity-Park et al., 2010) , forming an epigenetic field for cancerization (epigenetic field defect) (Ushijima, 2007) . Methylation levels of marker genes, which show high methylation levels, are correlated with those of tumor-suppressor genes, which tend to show very low methylation levels Ushijima, 2007) .
However, it is still unclear when such an epigenetic field defect is formed during chronic inflammationassociated carcinogenesis, and how aberrant DNA methylation is induced by chronic inflammation. As inflammation involves multiple types of cells at different time points, it is important to investigate mechanisms of how such a field defect is formed in vivo. Such in vivo analysis has been hampered by the lack of appropriate animal models in which chronic inflammation and aberrant DNA methylation are involved, except for a Helicobacter pylori infection-induced gastritis model in Mongolian gerbils (Niwa et al., 2010; Hur et al., 2011) . In mouse models, aberrant DNA methylation itself has been reported in lung (Vuillemenot et al., 2004) , skin (Fraga et al., 2004) , small intestine (Hahn et al., 2008) , and prostate (Yamashita et al., 2008) cancers and in hematological malignancies (Yu et al., 2005) .
In this study, we focused on a mouse colitis model induced by dextran sulfate sodium (DSS), which share some aspects with human ulcerative colitis (Rosenberg et al., 2009) , as a possible model in which an epigenetic field defect is involved. After identification of CGIs aberrantly methylated in azoxymethane (AOM) and DSS-induced mouse colon cancers, we clarified when aberrant DNA methylation is induced in colonic epithelial cells during colitis and what cells are critically involved in the induction.
Results

Identification of CGIs methylated in colitis-associated mouse colon tumors
We started by identifying CGIs specifically methylated in mouse colon tumors associated with colitis. AOM/ DSS-induced colon tumors and untreated normal colon epithelial samples were obtained from the animal experiment described in Figure 1a . Methylated DNA immunoprecipitation (MeDIP)-CGI microarray analysis was performed using a pool of the two tumors and a pool of two normal epithelial samples, and we isolated 23 candidate CGIs methylated in the tumors. Their methylation statuses were analyzed by methylationspecific PCR (MSP) of the samples used for the MeDIPmicroarray analysis, three additional colon tumors and normal epithelial samples obtained from untreated mice. Fifteen of the 23 CGIs were specifically methylated in four or more of the five tumors ( Figure 1b ; Table 1 ). The presence of densely methylated DNA molecules was further confirmed by bisulfite sequencing for three CGIs (Fosb, Hoxa5 and Krt7) in the five tumors ( Figure 1c ).
DNA methylation induction in colonic epithelial cells and its temporal profiles DNA methylation of the 15 CGIs was then analyzed in epithelial samples exposed to AOM and/or DSS by quantitative MSP (qMSP) (Figure 1d and Supplementary Figure S1 ). Fourteen of them had significantly increased methylation levels in epithelial samples of AOM/DSS-treated and DSS-treated mice but not in those of AOM-treated mice. This showed that DNA methylation of these CGIs was associated with DSS treatment.
Epithelial samples might be contaminated with infiltrating blood cells although they were prepared by the crypt isolation technique. We therefore analyzed methylation levels of the 14 CGIs in peripheral blood, and three (Fosb, Msx1 and Sox11) had low methylation levels (0-5.1 percentage of the methylated reference (PMR)) whereas the other 11 CGIs had high methylation levels (11-78 PMR; shown as numbers in parentheses in Figure 1d and Supplementary Figure S1 ). We further purified epithelial cells and blood leukocytes by fluorescence-activated cell sorting using Epcam (a panepithelial cell marker) and Cd45 (a pan-leukocyte marker), respectively, from colonic epithelial samples. At 15 weeks, methylation levels of the three CGIs with low methylation in peripheral blood (Fosb, Msx1, and Sox11) were significantly higher in the epithelial (Epcam-positive) cells of the DSS-treated mice than in those of untreated mice (7.3-to 19.3-fold; Supplementary Figure S3 ). These three CGIs were located inside the genes or in the 5 0 far upstream region of the gene. Using these three CGIs, temporal profiles of methylation induction were analyzed in the course of DSSinduced colitis (Figure 2a ). All the three CGIs showed gradual increases of DNA methylation levels, starting at 8 weeks after DSS treatment and reaching 7.4-to 9.2-fold high levels, compared with untreated controls, at 15 weeks (Figure 2b ). When the remaining 11 CGIs with high DNA methylation levels in peripheral blood were analyzed (Supplementary Figure S2) , three (Fut4, Hoxa5 and Mex3a) showed similar profiles to the above three CGIs and eight (5730596B20Rik, Bcl6b, Epcam, Fmnl1, Irf2bp, Nav1, Rara and Sh2d3c) showed a spiked increase immediately after the DSS treatment and a gradual decrease to control levels by 15 weeks.
No induction of aberrant DNA methylation by treatment of colonic epithelial cells with DSS in vitro DSS is known to have direct effects on epithelial cells, such as induction of cell growth arrest and production of cytokines (Ni et al., 1996; Araki et al., 2006) , and this raised a possibility that DSS might directly induce aberrant DNA methylation in colonic epithelial cells. To address this possibility, immortalized normal mouse colonic epithelial cells (LIF-16) were treated with four concentrations of DSS that inhibited cell growth in a dose-dependent manner ( Figure 3a) . As the maximum dose (2%) did not affect cellular morphology (Figure 3b ), the cells were cultured for 2, 5 and 8 weeks after 1 week of treatment with 2% DSS or in the presence of 2% DSS (Figure 3c ). The methylation levels of the three CGIs (Fosb, Msx1, and Sox11) in the DSStreated cells remained in the same range with those in untreated cells (Figure 3d ). This showed that DSS itself was unlikely to induce DNA methylation in colonic epithelial cells.
Temporal profiles of inflammatory cell infiltration after the DSS treatment
In the previous study, we found that aberrant DNA methylation is induced in gastric epithelial samples exposed to specific kinds of inflammation (Hur et al., 2011) . Because a direct effect of DSS on methylation induction was unlikely, inflammation triggered by the DSS treatment was suggested to be involved in the methylation induction. To identify specific inflammatory cells associated with DNA methylation induction, their infiltration was assessed by counting the number of infiltrating lymphocytes, macrophages, and neutrophils in colonic mucosae and submucosae ( Figure 2c ). Lymphocyte and neutrophil infiltration was most severe immediately after the DSS treatment, then gradually decreased, but was still present even at weeks 15. Macrophage infiltration stayed at high levels throughEpigenetic field defect in mouse colitis M Katsurano et al out the experimental period. These results showed that inflammation was present in the DSS-treated colon throughout the experimental period despite DSS being transiently administered, and that dominantly infiltrating cells shifted from neutrophils/lymphocytes to macrophages. The number of inflammatory cells did not parallel the temporal profiles of gradually increasing DNA methylation levels of the six CGIs (Fosb, Fut4, Hoxa5, Mex3a, Msx1 and Sox11).
Carcinogenicity and DNA methylation induction in severe combined immunodeficiency mice As the infiltration of inflammatory cells in wild-type (BALB/c) mice after DSS treatment was extensive, identification of specific inflammatory cells and inflammation-related genes responsible for DNA methylation induction was difficult. Therefore, we adopted a strategy of analyzing carcinogenicity and DNA methylation induction in severe combined immunodeficiency (SCID) mice (Figure 4a ), which lack functional T-and B-cells but have normal innate immunity (Bosma et al., 1983) . So far, there has been no report of aberrant methylation induction by DSS colitis in SCID mice. Tumor incidence and multiplicity showed no significant difference between SCID and its wild-type control, C.B17 ( Figure 4b ; Table 2 ), demonstrating that functional T-and B-cells are not essential for tumor induction in SCID mice. Methylation of Fosb, Msx1 and Sox11 was significantly induced in colonic epithelial samples of AOM/DSS-treated SCID mice to almost the same level as those in C.B17 mice (Figure 4c ), demonstrating that functional T-and B-cells are dispensable for methylation induction.
Expression of inflammation-related genes in DSS-treated SCID mice
Infiltration of inflammatory cells and expression levels of inflammation-related genes were analyzed in the Relative position to the gene (5 0 far upstream, a region more than 300 bp upstream of the transcription start site; 5 0 proximal upstream, a region within 300 bp upstream of the transcription start site; inside, a region in the exon or intron; and 3 0 downstream, a region within 10 kbp downstream of the last exon). colon of DSS-treated SCID mice at 8 weeks (Figure 4a , d and e). This time point was chosen because DNA methylation was increasing at this point in the DSS-treated BALB/c mice and was considered to be actively being induced. Quantification of inflammatory cells confirmed that there was little infiltration of lymphocytes in SCID mice. In contrast, infiltration of macrophages and neutrophils were induced both in SCID and C.B17 mice by DSS treatment. Treatment with only DSS was conducted because DSS only was sufficient for methylation induction (Figure 1d and Supplementary Figure S1 ) and we wanted to avoid any additional expression changes caused by AOM.
Among the eight inflammation-related genes analyzed, upregulation of Ifng, Il1b and Nos2 by DSS treatment was commonly observed in SCID and C.B17 mice (Figure 4e ). On the other hand, upregulation of four genes (Il2, Il6, Il10 and Tnf) was observed only in C.B17 mice, not in SCID mice. Cox2 expression was not induced by DSS treatment either in SCID or in C.B17 mice. As inflammation-related genes upregulated commonly in SCID and C.B17 mice were likely to be involved in DNA methylation induction, Ifng, Il1b and Nos2 were considered as candidates involved in DNA methylation induction.
Discussion
We here demonstrated that aberrant DNA methylation was induced in colonic epithelial cells as early as 8 weeks after DSS treatment, when no macroscopic tumors appeared, and the methylation level gradually increased until macroscopic tumors developed. The presence of aberrant DNA methylation in early stages of carcinogenesis was consistent with findings in Gpx1/2 double knockout mice, a model for human inflammatory bowel disease (Hahn et al., 2008) and in gastric epithelia of Mongolian gerbils exposed to Helicobacter pylori infection (Niwa et al., 2010; Hur et al., 2011) . The present study is unique in that DNA methylation levels gradually increased even if inflammation gradually diminished.
To investigate components of inflammation involved in methylation induction, we utilized SCID mice, and found that DNA methylation and colon tumors were induced in them to almost the same level as those in C.B17 mice. This clearly showed that functional T-and B-cells are non-essential for DNA methylation and tumor induction. Induction of colitis by DSS in SCID mice has long been known (Dieleman et al., 1994) , but tumor incidence has not been analyzed. This is the first study that showed DNA methylation and tumors are induced in SCID mice by AOM and DSS to almost the same level as those in wild-type mice. In SCID mice, infiltration of macrophages and neutrophils was almost at the same levels as in C.B17 mice. Considering the importance of chronic inflammation, it was suggested that macrophages could be the proximate effector for DNA methylation induction. Among the eight inflammation-related genes examined, Ifng, Il1b and Nos2 were upregulated by DSS treatment both in SCID and C.B17 mice.
The eight inflammation-related genes (Cox2, Ifng, Il1b, Il2, Il6, Il10, Nos2, and Tnf) examined here are known to show increased expression in inflamed human bowels (Cappello et al., 1992; McLaughlan et al., 1997; Autschbach et al., 2002; Li et al., 2009; Wang and Dubois, 2010) . Especially, IL1b is produced at significantly high levels also in human ulcerative colitis (Ligumsky et al., 1990) . In vitro, administration of IL1b is reported to induce DNA methylation through induction of Nos2 (Hmadcha et al., 1999) and in CDH1 promoter (Qian et al., 2008) . INFg is reported to be involved in initiation of DSS-induced colitis (Ito et al., 2006) and in development of colon tumors in Socs1-deficient mice (Hanada et al., 2006) , but its role in induction of aberrant DNA methylation is still unknown. Il6 is known to induce DNA methyltransferase expression (Hodge et al., 2001) , and its deficiency in mice leads to decreased tumor number and size after AOM and DSS treatment (Grivennikov et al., 2009) . Il2 and Il10 deficiency in mice leads to development of spontaneous colitis (Kuhn et al., 1993; Sadlack et al., 1993) . Blocking of Tnf signal reduced tumor number after AOM and DSS treatment (Popivanova et al., 2008) .
Technically, the MeDIP-CGI microarray analysis isolated 23 candidate CGIs methylated in primary 
Epigenetic field defect in mouse colitis
M Katsurano et al mouse colon tumors. The number was smaller than expected from the known finding that 170-621 CGIs are methylated in human colon cancers (Keshet et al., 2006; Kim et al., 2011) . However, using the same cutoff values used in this study, we were able to isolate 2339 methylated CGIs in a mouse colon cancer cell line, Colon26 (data not shown). Therefore, it was unlikely that there was a technical problem, and it was suggested that the mouse primary colon tumors had much smaller numbers of methylated CGIs than the Colon26 mouse colon cancer cell line and human colon cancers. In summary, by DSS-induced inflammation, aberrant DNA methylation was shown to start to accumulate in epithelial cells at early stages of carcinogenesis. T-and B-cells were non-essential for DNA methylation induction.
Materials and methods
Cell line and DSS treatment LIF-16, an embryonic colonic epithelial cell line established from Trp53
À/À mice as described previously (Taniwaki et al., 2007) , was kindly provided by Dr Hiroshi Fukamachi at Tokyo Medical and Dental University and maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. For cell growth assay, 10 5 cells were plated. After attachment of the cells, the culture media were replaced by those containing DSS (molecular weight ¼ 36 000À50 000; MP Biochemicals, Solon, OH, USA). The cell number was counted by a Countess automated cell counter (Invitrogen, Rockville, MD, USA). For methylation assay, 5 Â 10 3 cells were plated on 6 cm dishes. Every third or fourth day, the cells were passaged using Dulbecco's modified Eagle's medium without DSS, and DSS was added after attachment of the cells during the duration described in Figure 3c .
Animals and cancer induction experiments
Male BALB/c mice were purchased from Charles River Laboratories (Yokohama, Japan). Male C.B17/Icr-scid/scid (SCID) and C.B17/Icr-þ / þ (C.B17) mice were purchased from CLEA Japan (Tokyo, Japan). AOM (10 mg/kg body weight; NARD Institute, Amagasaki, Japan) or phosphate-buffered saline (PBS) was administered by single intraperitoneal injection. DSS (molecular weight ¼ 36 000À50 000) was administered to mice at 6 or 7 weeks of age in drinking water at a concentration of 1.5 or 2.0% w/v. Colon cancers and colonic epithelial samples for MeDIP-CGI microarray analysis were obtained from BALB/c mice treated with AOM and DSS (Figure 1a ; Supplementary Table S1), which showed similar carcinogenicity to our previous reports (Tanaka et al., 2003) . All the animal experiments were approved by the Committee for Ethics in Animal Experimentation at the National Cancer Center.
Sample preparation
The large bowel was cut open longitudinally and the number of macroscopic tumors whose major axes were more than 3 mm was counted. Large tumors were collected and half of each tumor was fixed with neutralized 10% formalin for histological analysis and the other half was kept frozen for Epigenetic field defect in mouse colitis M Katsurano et al DNA and RNA isolation. Colonic epithelial samples were isolated from distal large bowels by the crypt isolation technique (Cheng et al., 1984) . Briefly, the distal half of the large bowel was incubated in a Hanks' balanced salt solution with 30 mM EDTA at 37 1C for 10 min. After the incubation, epithelium was collected by scraping off gently and washed with PBS. Peripheral blood was obtained from the inferior vena cava of DSS-treated and non-treated mice at 22 weeks of age.
Fluorescence-activated cell sorting
To dissociate single cells, epithelial samples were incubated in Hanks' balanced salt solution containing 10 mM HEPES (pH7.3), 1 mg/ml collagenase D (Roche Diagnostics, Penzberg, Germany) and 25 mg/mL DNase I (Sigma-Aldrich, St Louis, MO, USA) at 37 1C for 80 min with gentle agitation. The cells were washed with PBS and then fixed with 80% acetone at 4 1C for 5 min. After washing with PBS, the fixed cells were incubated with a phycoerythrin-labeled anti-mouse Epcam antibody (eBiosciense, San Diego, CA, USA) and a 
Nucleic acid isolation
From colonic epithelial samples and cells purified by fluorescence-activated cell sorting, genomic DNA was extracted by the standard phenol/chloroform method, and RNA was isolated using ISOGEN (Nippon Gene, Tokyo, Japan). Genomic DNA of peripheral blood was extracted by a QuickGene DNA whole blood kit (Fujifilm, Tokyo, Japan).
MeDIP-CGI microarray
MeDIP-CGI microarray analysis was performed as previously described Yamashita et al., 2009 Technologies) . Scanned data were processed with Feature Extraction Ver.9.1 and Agilent G4477AA ChIP Analytics 1.3 software (Agilent Technologies). Probes with signal log ratio X0.5 in a tumor sample and p À0.2 in a normal sample were considered to be methylated, and CGIs in which two or more continuous probes were methylated and at least one probe had a normalized log ratio more than 1.2 were considered as methylated.
MSP, qMSP and bisulfite sequencing
Bisulfite modification was performed using 1 mg of BamHIdigested genomic DNA as previously described (Yamashita et al., 2008) . The sample was resuspended in 40 ml of Tris-EDTA buffer, and an aliquot of 1 ml was used for MSP (qMSP) and bisulfite sequencing. Fully methylated and fully unmethylated DNA were prepared by amplifying mouse genomic DNA with GenomiPhi and by methylating it with SssI methylase, respectively (Niwa et al., 2005) . Primers for MSP (Supplementary Table S2 ) were designed within B100 bp from methylated probes. Primers for bisulfite sequencing were designed to cover the region amplified by MSP (Supplementary Table S2 ). qMSP was performed by real-time PCR using SYBR Green I (BioWhittaker Molecular Applications, Rockland, ME, USA) and an iCycler Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA) in duplicate. The number of molecules in a sample was determined by comparing its amplification with those of standard DNA prepared by purification of PCR products. The number was highly reproducible using the same samples (correlation coefficient 40.8). DNA methylation levels were expressed as a PMR, which reflected a fraction of the DNA molecules methylated at a specific locus (Kass et al., 1997; Niwa et al., 2010) . PMR was calculated as ((no of molecules methylated at a target CGI in a sample)/(no of B2 SINE repeat in the sample))/((no of molecules methylated at the target CGI in a SssI-treated DNA)/(no of B2 SINE repeat in the SssI-treated DNA)) Â 100.
Reverse transcriptase-PCR
Complementary DNA was synthesized from 2 mg of total RNA using a Superscript III kit (Invitrogen) with oligo dT primer. Real-time PCR was performed with gene-specific primers (Supplementary Table 3 ) as described in qMSP. The complementary DNA quantity of each gene was normalized to that of Gapdh.
Statistical analysis
Differences in DNA methylation and expression levels were analyzed by the Mann-Whitney U test using SPSS 13.0J.
(SPSS Japan Inc., Tokyo, Japan).
